SA resumption of vaccine drive expected to stabilise market

South Africa is expected to resume the use of the Johnson & Johnson vaccine to immunise healthcare workers soon, a move that is expected to bring stability in the markets as Covid-19 cases are on the rise. (Photo by JUSTIN TALLIS / AFP)
SA resumption of vaccine drive expected to stabilise market
By Siphelele Dludla
Share
JOHANNESBURG - SOUTH Africa is expected to resume the use of the Johnson & Johnson vaccine to immunise healthcare workers soon, a move that is expected to bring stability in the markets as Covid-19 cases are on the rise.
Confidence in the global economic recovery has been rising due to the success of vaccination roll-outs in various countries with investors in South African markets keeping a keen eye on the speed of vaccine delivery as well as the virus infection rate.

Related Keywords

South Africa ,Johannesburg ,Gauteng ,Free State ,India ,Brazil ,South African ,Lukman Otunnuga ,Khumbudzo Ntshavheni ,Pfizer ,Department Of Health ,Jj Sisonke Vaccination Programme ,Sisonke Vaccination Programme ,Johnson ,Sa Health Products Regulatory Authority Sahpra ,Presidency Khumbudzo Ntshavheni ,Products Regulatory Authority ,ஜோகன்னஸ்பர்க் ,கௌஊட்டெங் ,இலவசம் நிலை ,இந்தியா ,பிரேசில் ,ஃபைசர் ,துறை ஆஃப் ஆரோக்கியம் ,ஜான்சன் ,ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் ,